Vitamin D and systemic lupus erythematosus: an update

References

• Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol. Metab. Clin. North Am. 39(2), 255–269 (2010).
   PubMed Web of Science ®Google Scholar
• Adams JS, Hewison M. Update in vitamin D. J. Clin. Endocrinol. Metab. 95(2), 471–478 (2010).
   PubMed Web of Science ®Google Scholar
• Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol. Metab. Clin. North Am. 39(2), 365–379 (2010).
   PubMed Web of Science ®Google Scholar
• Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol. 4(8), 404–412 (2008).
   PubMedGoogle Scholar
• Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10(4), 482–496 (2010).
   PubMed Web of Science ®Google Scholar
• Gombart AF. The vitamin D – antimicrobial peptide pathway and its role in protection against infection. Future Microbiol. 4(9), 1151–1165 (2009).
   PubMed Web of Science ®Google Scholar
• Martineau AR, Wilkinson KA, Newton SM et al. IFN-γ- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J. Immunol. 178(11), 7190–7198 (2007).
   PubMed Web of Science ®Google Scholar
• Gauzzi MC, Purificato C, Donato K et al. Suppressive effect of 1α,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis. J. Immunol. 174(1), 270–276 (2005).
   PubMed Web of Science ®Google Scholar
• Baeke F, Korf H, Overbergh L et al. The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J. Immunol. 186(1), 132–142 (2011).
   PubMed Web of Science ®Google Scholar
• Bartels LE, Hvas CL, Agnholt J, Dahlerup JF, Agger R. Human dendritic cell antigen presentation and chemotaxis are inhibited by intrinsic 25-hydroxy vitamin D activation. Int. Immunopharmacol. 10(8), 922–928 (2010).
   PubMed Web of Science ®Google Scholar
• Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 179(3), 1634–1647 (2007).
   PubMed Web of Science ®Google Scholar
• Shirakawa AK, Nagakubo D, Hieshima K, Nakayama T, Jin Z, Yoshie O. 1,25-dihydroxyvitamin D3 induces CCR10 expression in terminally differentiating human B cells. J. Immunol. 180(5), 2786–2795 (2008).
   PubMed Web of Science ®Google Scholar
• Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J. Clin. Pathol. 56(7), 481–490 (2003).
   PubMed Web of Science ®Google Scholar
• Katsiari CG, Liossis SN, Sfikakis PP. The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal. Semin. Arthritis Rheum. 39(6), 491–503 (2010).
   PubMed Web of Science ®Google Scholar
• Fransen JH, van der Vlag J, Ruben J, Adema GJ, Berden JH, Hilbrands LB. The role of dendritic cells in the pathogenesis of systemic lupus erythematosus. Arthritis Res. Ther. 12(2), 207 (2010).
   PubMed Web of Science ®Google Scholar
• Linker-Israeli M, Elstner E, Klinenberg JR, Wallace DJ, Koeffler HP. Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin. Immunol. 99(1), 82–93 (2001).
   PubMed Web of Science ®Google Scholar
• Ben-Zvi I, Aranow C, Mackay M et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One 5(2), e9193 (2010).
   PubMed Web of Science ®Google Scholar
• Ritterhouse LL, Crowe SR, Niewold TB et al. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 70(9), 1569–1574 (2011).
   PubMed Web of Science ®Google Scholar
• Pelajo CF, Lopez-Benitez JM, Miller LC. Vitamin D and autoimmune rheumatologic disorders. Autoimmun. Rev. 9(7), 507–510 (2010).
   PubMed Web of Science ®Google Scholar
• Gatenby P, Lucas R, Swaminathan A. Vitamin D deficiency and risk for rheumatic diseases: an update. Curr. Opin. Rheumatol. 25(2), 184–191 (2013).
   PubMed Web of Science ®Google Scholar
• Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun. Rev. 5(2), 114–117 (2006).
   PubMed Web of Science ®Google Scholar
• Bonakdar ZS, Jahanshahifar L, Jahanshahifar F, Gholamrezaei A. Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus 20(11), 1155–1160 (2011).
   PubMed Web of Science ®Google Scholar
• Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito-Garcia E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann. Rheum. Dis. 67(4), 530–535 (2008).
   PubMed Web of Science ®Google Scholar
• Hiraki LT, Munger KL, Costenbader KH, Karlson EW. Dietary intake of vitamin D during adolescence and risk of adult-onset systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res. (Hoboken) 64(12), 1829–1836 (2012).
   PubMed Web of Science ®Google Scholar
• Disanto G, Chaplin G, Morahan JM et al. Month of birth, vitamin D and risk of immune mediated disease: a case–control study. BMC Med. 10(1), 69 (2012).
   PubMed Web of Science ®Google Scholar
• Singh A, Kamen DL. Potential benefits of vitamin D for patients with systemic lupus erythematosus. Dermatoendocrinol. 4(2), 146–151 (2012).
   PubMedGoogle Scholar
• Sumethkul K, Boonyaratavej S, Kitumnuaypong T et al. The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus. Rheumatol. Int. doi:10.1007/s00296-012-2537-7 (2012) (Epub ahead of print).
   PubMedGoogle Scholar
• Casella CB, Seguro LP, Takayama L, Medeiros D, Bonfa E, Pereira RM. Juvenile onset systemic lupus erythematosus: a possible role for vitamin D in disease status and bone health. Lupus 21(12), 1335–1342 (2012).
   PubMed Web of Science ®Google Scholar
• Mok CC, Birmingham DJ, Leung HW, Hebert LA, Song H, Rovin BH. Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford) 51(4), 644–652 (2012).
   PubMed Web of Science ®Google Scholar
• Souto M, Coelho A, Guo C et al. Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors, and relationship with activity. Lupus 20(10), 1019–1026 (2011).
   PubMed Web of Science ®Google Scholar
• Hamza RT, Awwad KS, Ali MK, Hamed AI. Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity. Med. Sci. Monit. 17(12), CR711–CR718 (2011).
   PubMed Web of Science ®Google Scholar
• López-Robles C, Rios-Fernández R, Callejas-Rubio JL, Ortego-Centeno N. Vitamin D deficiency in a cohort of patients with systemic lupus erythematosus from the south of Spain. Lupus 20(3), 330–331 (2011).
   PubMed Web of Science ®Google Scholar
• Amital H, Szekanecz Z, Szücs G et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann. Rheum. Dis. 69(6), 1155–1157 (2010).
   PubMed Web of Science ®Google Scholar
• Ruiz-Irastorza G, Gordo S, Olivares N, Egurbide MV, Aguirre C. Changes in vitamin D levels in patients with systemic lupus erythematosus: effects on fatigue, disease activity, and damage. Arthritis Care Res. (Hoboken) 62(8), 1160–1165 (2010).
   PubMed Web of Science ®Google Scholar
• Cutillas-Marco E, Morales-Suárez-Varela M, Marquina-Vila A, Grant W. Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region. Lupus 19(7), 810–814 (2010).
   PubMed Web of Science ®Google Scholar
• Kim HA, Sung JM, Jeon JY, Yoon JM, Suh CH. Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus. Rheumatol. Int. 31(9), 1189–1194 (2011).
   PubMed Web of Science ®Google Scholar
• Szodoray P, Tarr T, Bazso A, Poor G, Szegedi G, Kiss E. The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary. Scand. J. Rheumatol. 40(2), 122–126 (2011).
   PubMed Web of Science ®Google Scholar
• Toloza SM, Cole DE, Gladman DD, Ibañez D, Urowitz MB. Vitamin D insufficiency in a large female SLE cohort. Lupus 19(1), 13–19 (2010).
   PubMed Web of Science ®Google Scholar
• Wu PW, Rhew EY, Dyer AR et al. 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum. 61(10), 1387–1395 (2009).
   PubMed Web of Science ®Google Scholar
• Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos. Int. 20(3), 427–433 (2009).
   PubMed Web of Science ®Google Scholar
• Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 47(6), 920–923 (2008).
   PubMed Web of Science ®Google Scholar
• Cusack C, Danby C, Fallon JC et al. Photoprotective behaviour and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus. Photodermatol. Photoimmunol. Photomed. 24(5), 260–267 (2008).
   PubMed Web of Science ®Google Scholar
• Orbach H, Zandman-Goddard G, Amital H et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann. NY Acad. Sci. 1109, 385–400 (2007).
   PubMed Web of Science ®Google Scholar
• Fraser WD, Milan AM. Vitamin D assays: past and present debates, difficulties, and developments. Calcif. Tissue Int. 92(2), 118–127 (2013).
   PubMed Web of Science ®Google Scholar
• Shoenfeld N, Amital H, Shoenfeld Y. The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat. Clin. Pract. Rheumatol. 5(2), 99–105 (2009).
   PubMedGoogle Scholar
• Earthman CP, Beckman LM, Masodkar K, Sibley SD. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int. J. Obes. (Lond.) 36(3), 387–396 (2012).
   PubMed Web of Science ®Google Scholar
• Reynolds JA, Haque S, Berry JL et al. 25-hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology (Oxford) 51(3), 544–551 (2012).
   PubMed Web of Science ®Google Scholar
• Wright TB, Shults J, Leonard MB, Zemel BS, Burnham JM. Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J. Pediatr. 155(2), 260–265 (2009).
   PubMed Web of Science ®Google Scholar
• Kamen DL. Vitamin D in lupus – new kid on the block? Bull. NYU Hosp. Jt Dis. 68(3), 218–222 (2010).
   PubMedGoogle Scholar
• Meier C, Kraenzlin ME. Antiepileptics and bone health. Ther. Adv. Musculoskelet. Dis. 3(5), 235–243 (2011).
   PubMedGoogle Scholar
• Mok CC, Tong KH, To CH, Siu YP, Au TC. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study. Kidney Int. 68(2), 813–817 (2005).
   PubMed Web of Science ®Google Scholar
• Lee CT, Ng HY, Lien YH et al. Effects of cyclosporine, tacrolimus and rapamycin on renal calcium transport and vitamin D metabolism. Am. J. Nephrol. 34(1), 87–94 (2011).
   PubMed Web of Science ®Google Scholar
• Grenet O, Bobadilla M, Chibout SD, Steiner S. Evidence for the impairment of the vitamin D activation pathway by cyclosporine A. Biochem. Pharmacol. 59(3), 267–272 (2000).
   PubMed Web of Science ®Google Scholar
• Adams JS, Diz MM, Sharma OP. Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann. Intern. Med. 111(5), 437–438 (1989).
   PubMed Web of Science ®Google Scholar
• Barré PE, Gascon-Barré M, Meakins JL, Goltzman D. Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis. Am. J. Med. 82(6), 1259–1262 (1987).
   PubMed Web of Science ®Google Scholar
• O’Leary TJ, Jones G, Yip A, Lohnes D, Cohanim M, Yendt ER. The effects of chloroquine on serum 1,25-dihydroxyvitamin D and calcium metabolism in sarcoidosis. N. Engl. J. Med. 315(12), 727–730 (1986).
   PubMed Web of Science ®Google Scholar
• Huisman AM, White KP, Algra A et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J. Rheumatol. 28(11), 2535–2539 (2001).
   PubMed Web of Science ®Google Scholar
• Mok CC, Birmingham DJ, Ho LY, Hebert LA, Song H, Rovin BH. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus 21(1), 36–42 (2012).
   PubMed Web of Science ®Google Scholar
• Reddy Vanga S, Good M, Howard PA, Vacek JL. Role of vitamin D in cardiovascular health. Am. J. Cardiol. 106(6), 798–805 (2010).
   PubMed Web of Science ®Google Scholar
• Reis JP, von Mühlen D, Michos ED et al. Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis 207(2), 585–590 (2009).
   PubMed Web of Science ®Google Scholar
• de Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, Siscovick DS. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J. Am. Soc. Nephrol. 20(8), 1805–1812 (2009).
   PubMed Web of Science ®Google Scholar
• Anderson JL, May HT, Horne BD et al.; Intermountain Heart Collaborative (IHC) Study Group. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106(7), 963–968 (2010).
   PubMed Web of Science ®Google Scholar
• Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am. J. Cardiol. 102(11), 1540–1544 (2008).
   PubMed Web of Science ®Google Scholar
• Baz-Hecht M, Goldfine AB. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr. Opin. Endocrinol. Diabetes. Obes. 17(2), 113–119 (2010).
   PubMedGoogle Scholar
• Martins D, Wolf M, Pan D et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 167(11), 1159–1165 (2007).
   PubMed Web of Science ®Google Scholar
• Wang L, Song Y, Manson JE et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes 5(6), 819–829 (2012).
   PubMed Web of Science ®Google Scholar
• Zhao G, Ford ES, Li C, Croft JB. Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. J. Hypertens. 30(2), 284–289 (2012).
   PubMed Web of Science ®Google Scholar
• Correia LC, Sodré F, Garcia G et al. Relation of severe deficiency of vitamin D to cardiovascular mortality during acute coronary syndromes. Am. J. Cardiol. 111(3), 324–327 (2013).
   PubMed Web of Science ®Google Scholar
• Mok CC. Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus. Scand. J. Rheumatol. 35(2), 85–95 (2006).
   PubMed Web of Science ®Google Scholar
• Ravenell RL, Kamen DL, Spence JD et al. Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients. Am. J. Med. Sci. 344(4), 268–273 (2012).
   PubMed Web of Science ®Google Scholar
• Alele JD, Kamen DL. The importance of inflammation and vitamin D status in SLE-associated osteoporosis. Autoimmun. Rev. 9(3), 137–139 (2010).
   PubMed Web of Science ®Google Scholar
• Yeap SS, Othman AZ, Zain AA, Chan SP. Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids. Int. J. Rheum. Dis. 15(1), 17–24 (2012).
   PubMed Web of Science ®Google Scholar
• Bischoff HA, Borchers M, Gudat F et al. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem. J. 33(1), 19–24 (2001).
   PubMedGoogle Scholar
• Prabhala A, Garg R, Dandona P. Severe myopathy associated with vitamin D deficiency in western New York. Arch. Intern. Med. 160(8), 1199–1203 (2000).
   PubMed Web of Science ®Google Scholar
• Korenromp IH, Heijnen CJ, Vogels OJ, van den Bosch JM, Grutters JC. Characterization of chronic fatigue in patients with sarcoidosis in clinical remission. Chest 140(2), 441–447 (2011).
   PubMed Web of Science ®Google Scholar
• Stockton KA, Kandiah DA, Paratz JD, Bennell KL. Fatigue, muscle strength and vitamin D status in women with systemic lupus erythematosus compared with healthy controls. Lupus 21(3), 271–278 (2012).
   PubMed Web of Science ®Google Scholar
• Heaney RP, Recker RR, Grote J, Horst RL, Armas LA. Vitamin D(3) is more potent than vitamin D(2) in humans. J. Clin. Endocrinol. Metab. 96(3), E447–E452 (2011).
   PubMed Web of Science ®Google Scholar
• Grossman JM, Gordon R, Ranganath VK et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res. (Hoboken) 62(11), 1515–1526 (2010).
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N. Engl. J. Med. 357(3), 266–281 (2007).
   PubMed Web of Science ®Google Scholar
• Abou-Raya A, Abou-Raya S, Helmii M. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J. Rheumatol. 40(3), 265–272 (2013).
   PubMed Web of Science ®Google Scholar
• Terrier B, Derian N, Schoindre Y et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res. Ther. 14(5), R221 (2012).
   Web of Science ®Google Scholar
• Hartmann B, Heine G, Babina M et al. Targeting the vitamin D receptor inhibits the B cell-dependent allergic immune response. Allergy 66(4), 540–548 (2011).
   PubMed Web of Science ®Google Scholar
• Sochorová K, Budinský V, Rozková D et al. Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells. Clin. Immunol. 133(1), 69–77 (2009).
   PubMed Web of Science ®Google Scholar
• Laverny G, Penna G, Vetrano S et al. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease. Immunol. Lett. 131(1), 49–58 (2010).
   PubMed Web of Science ®Google Scholar